Skip to main content
. 2016 May 4;20:120. doi: 10.1186/s13054-016-1305-6

Fig. 4.

Fig. 4

Pneumonia outcome. Data from 12 trials (n = 1471 patients) were included, analyzed using the random effects model. The risk of pneumonia was similar in both groups. PPI proton pump inhibitor, H2RA histamine-2-receptor antagonist. IV Inverse Variance